Woman Was Given “Wonderdrug” During Pregnancy

Stilboestrol, the drug also known as diethylstilboestrol or DES, was widely prescribed to pregnant women between the 1940s and early 1970s, including in Australia, to prevent miscarriage and support pregnancy.

It was later linked to severe health risks for their children, now known as “DES daughters” and “DES sons”.

Elevated Cancer Risks Uncovered Because of the Drug

Women exposed in utero (DES daughters) face significantly higher risks of rare cancers:

• They are about 40 times more likely to develop clear cell adenocarcinoma of the vagina or cervix, a rare cancer first identified in the 1970s.
• They may have a modestly increased risk of breast cancer after age 40, with studies showing up to double the risk compared to unexposed peers.
• Slightly higher occurrences of cervical dysplasia, pancreatic cancer, and early menopause have also been observed.

Overall, cancer risk isn’t dramatically elevated, but specific risks warrant vigilant monitoring .

The Drug & Its Effects Beyond Cancer

DES daughters frequently experience structural changes in reproductive organs—such as vaginal adenosis, T-shaped uterus, and cervical abnormalities—which can complicate fertility, pregnancy, and contraception.

For DES sons, common issues include undescended testicles, cysts, and lower sperm counts, though links to testicular cancer remain inconclusive.

Healthcare Response and Screening Guidelines

Worldwide, medical guidelines recommend that women known to be DES-exposed receive annual pelvic and cervical exams. This includes colposcopy and cytological (Pap) testing indefinitely. Routine breast screenings (mammograms and self-exams) are advised from age 40 onwards.

Men with prenatal DES exposure are encouraged to monitor for testicular changes and discuss risks with their doctors.

A Global Public Health Lesson From the Drug

DES was one of the first transplacental carcinogens discovered in humans, reshaping how drug safety for pregnant women is regulated. An estimated 11 million women worldwide took DES during pregnancy, prompting generational health monitoring for millions of their children.

Empowered Awareness Through Knowledge

For those unsure if they were exposed, checking medical records and requesting DES-specific examinations is critical. Early detection of precancerous changes can improve outcomes significantly.

This story underscores the importance of long-term follow-up when early medical treatments are later found harmful, and the need for transparency in maternal-fetal medicine.

You might also want to read: Young Adults at Greater Risk as Colorectal Cancer Cases Rise